Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial
Rationale & Objective: The risk implications of the Kidney Disease: Improving Global Outcomes (KDIGO) CKD classification in older adults are controversial. We evaluated the risk of adverse outcomes in this population across categories of estimated glomerular filtration rate (eGFR) and urine albu...
- Autores:
-
Turbay-Caballero, Valentina
Ricardo, Ana C.
Chen, Jinsong
Missikpode, Celestin
Lash, James P.
Aroca-Martinez, Gustavo
Musso, Carlos G.
- Tipo de recurso:
- Fecha de publicación:
- 2024
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/14676
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/14676
https://www.kidneymedicinejournal.org/action/showPdf?pii=S2590-0595%2824%2900056-6
- Palabra clave:
- KDIGO
CKD
Albuminuria
SPRINT trial
Cardiovascular events
- Rights
- openAccess
- License
- http://purl.org/coar/access_right/c_abf2
id |
USIMONBOL2_d694e349c26e08f8c08a18f87ed55b45 |
---|---|
oai_identifier_str |
oai:bonga.unisimon.edu.co:20.500.12442/14676 |
network_acronym_str |
USIMONBOL2 |
network_name_str |
Repositorio Digital USB |
repository_id_str |
|
dc.title.eng.fl_str_mv |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
title |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
spellingShingle |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial KDIGO CKD Albuminuria SPRINT trial Cardiovascular events |
title_short |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
title_full |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
title_fullStr |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
title_full_unstemmed |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
title_sort |
Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial |
dc.creator.fl_str_mv |
Turbay-Caballero, Valentina Ricardo, Ana C. Chen, Jinsong Missikpode, Celestin Lash, James P. Aroca-Martinez, Gustavo Musso, Carlos G. |
dc.contributor.author.none.fl_str_mv |
Turbay-Caballero, Valentina Ricardo, Ana C. Chen, Jinsong Missikpode, Celestin Lash, James P. Aroca-Martinez, Gustavo Musso, Carlos G. |
dc.subject.eng.fl_str_mv |
KDIGO CKD Albuminuria SPRINT trial Cardiovascular events |
topic |
KDIGO CKD Albuminuria SPRINT trial Cardiovascular events |
description |
Rationale & Objective: The risk implications of the Kidney Disease: Improving Global Outcomes (KDIGO) CKD classification in older adults are controversial. We evaluated the risk of adverse outcomes in this population across categories of estimated glomerular filtration rate (eGFR) and urine albumin to creatinine ratio (UACR). Study Design: Prospective cohort. Settings & Participants: 2509 participants aged ≥75 years in the Systolic Blood Pressure Intervention Trial (SPRINT). Exposures: KDIGO eGFR and UACR categories. We combined KDIGO categories G1 and G2, G3b and G4, as well as A2 and A3. Outcomes: Primary SPRINT outcome (composite of myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes), and all-cause death. Analytical Approach: Multivariable Cox proportional hazard models. Results: Mean age was 79.8 years, 37.4% were female, mean eGFR was 64.0 ml/min/1.73 m2, and median UACR 13.1 mg/g. In multivariable Cox proportional hazard analysis, compared with participants with eGFR ≥60 ml/min/1.73 m2 and UACR <30 mg/g, there was no statistically significant difference in the risk of the primary outcome among participants with eGFR 45-59 or 15-44 ml/min/1.73 m2 and UACR <30 mg/g. However, those with eGFR 45-59 or 15-44 ml/min/1.73 m2 and UACR ≥30 mg/g had higher risk of the primary outcome (HR [95% CI], 1.97 [1.27, 3.04] and 3.32 [2.23, 4.93], respectively). The risk for all-cause death was higher for each category of abnormal eGFR and UACR, with the highest risk observed among those with eGFR 15-44 ml/min/1.73 m2 and UACR ≥30 mg/g (3.34 [2.05, 5.44]). Limitations: Individuals with diabetes and urine protein >1 g/day were excluded from SPRINT. Conclusion: Among older adults SPRINT participants, low eGFR without albuminuria was associated with higher mortality but not with increased risk of cardiovascular events. Additional studies are needed to evaluate an adapted CKD stage-based risk stratification for older adults. |
publishDate |
2024 |
dc.date.accessioned.none.fl_str_mv |
2024-05-21T14:24:59Z |
dc.date.available.none.fl_str_mv |
2024-05-21T14:24:59Z |
dc.date.issued.none.fl_str_mv |
2024 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.driver.eng.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.spa.spa.fl_str_mv |
Artículo científico |
dc.identifier.citation.none.fl_str_mv |
Turbay-Caballero V, Ricardo AC, Chen J, Missikpode C, Lash JP, Aroca- Martinez G, Musso CG, CKD Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial, Kidney Medicine (2024), doi: https://doi.org/10.1016/j.xkme.2024.100845. |
dc.identifier.issn.none.fl_str_mv |
25900595 (Online) |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12442/14676 |
dc.identifier.doi.none.fl_str_mv |
10.1016/ j.xkme.2024.100845 |
dc.identifier.url.none.fl_str_mv |
https://www.kidneymedicinejournal.org/action/showPdf?pii=S2590-0595%2824%2900056-6 |
identifier_str_mv |
Turbay-Caballero V, Ricardo AC, Chen J, Missikpode C, Lash JP, Aroca- Martinez G, Musso CG, CKD Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial, Kidney Medicine (2024), doi: https://doi.org/10.1016/j.xkme.2024.100845. 25900595 (Online) 10.1016/ j.xkme.2024.100845 |
url |
https://hdl.handle.net/20.500.12442/14676 https://www.kidneymedicinejournal.org/action/showPdf?pii=S2590-0595%2824%2900056-6 |
dc.language.iso.eng.fl_str_mv |
eng |
language |
eng |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.accessrights.eng.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
pdf |
dc.publisher.eng.fl_str_mv |
National Kidney Foundation |
dc.source.eng.fl_str_mv |
Kidney Medicine Kidney Med |
dc.source.none.fl_str_mv |
Vol. 6 No. 7, (2024 ) |
institution |
Universidad Simón Bolívar |
bitstream.url.fl_str_mv |
https://bonga.unisimon.edu.co/bitstreams/0388ba63-36b9-405d-a1d9-93d260f51bee/download https://bonga.unisimon.edu.co/bitstreams/f33eb076-e29f-47ee-804d-2097049e306b/download https://bonga.unisimon.edu.co/bitstreams/cd5c7cea-649e-435f-9fb8-f88f24053e60/download https://bonga.unisimon.edu.co/bitstreams/3ea16ed0-5102-421d-8c28-3ec7a56abe7f/download https://bonga.unisimon.edu.co/bitstreams/27841eda-32aa-40c5-8e82-27f134dae84b/download https://bonga.unisimon.edu.co/bitstreams/ab4c9192-00ef-45a8-91f4-787823468890/download |
bitstream.checksum.fl_str_mv |
48a246f79846a95d8f60fcf806c22e40 733bec43a0bf5ade4d97db708e29b185 9b3c7af02929f6088e10c3b7560c65ab c7d37bd0424432fd8e5fbf44655b4d2b e1ba666e4736da80554528192656cb79 e1ba666e4736da80554528192656cb79 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Digital Universidad Simón Bolívar |
repository.mail.fl_str_mv |
repositorio.digital@unisimon.edu.co |
_version_ |
1814076109657997312 |
spelling |
Turbay-Caballero, Valentina3520e12b-ecfd-4cc2-aae0-8ae53beea374-1Ricardo, Ana C.cdf5cbf6-4be1-4672-9e88-02ba2ec21630-1Chen, Jinsong9e23fb1e-a20f-4c6f-ac7f-366f12b5480c-1Missikpode, Celestin2cebbc7a-9d7e-42c9-b6c0-369dc6fd414c-1Lash, James P.fd965966-41f2-4cf3-8785-0cdc5e652b00-1Aroca-Martinez, Gustavo9ebd2f8e-91b1-462f-a15a-09db2a45ce2b-1Musso, Carlos G.b310094b-baeb-4838-bde5-206ff4744824-12024-05-21T14:24:59Z2024-05-21T14:24:59Z2024Turbay-Caballero V, Ricardo AC, Chen J, Missikpode C, Lash JP, Aroca- Martinez G, Musso CG, CKD Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial, Kidney Medicine (2024), doi: https://doi.org/10.1016/j.xkme.2024.100845.25900595 (Online)https://hdl.handle.net/20.500.12442/1467610.1016/ j.xkme.2024.100845https://www.kidneymedicinejournal.org/action/showPdf?pii=S2590-0595%2824%2900056-6Rationale & Objective: The risk implications of the Kidney Disease: Improving Global Outcomes (KDIGO) CKD classification in older adults are controversial. We evaluated the risk of adverse outcomes in this population across categories of estimated glomerular filtration rate (eGFR) and urine albumin to creatinine ratio (UACR). Study Design: Prospective cohort. Settings & Participants: 2509 participants aged ≥75 years in the Systolic Blood Pressure Intervention Trial (SPRINT). Exposures: KDIGO eGFR and UACR categories. We combined KDIGO categories G1 and G2, G3b and G4, as well as A2 and A3. Outcomes: Primary SPRINT outcome (composite of myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes), and all-cause death. Analytical Approach: Multivariable Cox proportional hazard models. Results: Mean age was 79.8 years, 37.4% were female, mean eGFR was 64.0 ml/min/1.73 m2, and median UACR 13.1 mg/g. In multivariable Cox proportional hazard analysis, compared with participants with eGFR ≥60 ml/min/1.73 m2 and UACR <30 mg/g, there was no statistically significant difference in the risk of the primary outcome among participants with eGFR 45-59 or 15-44 ml/min/1.73 m2 and UACR <30 mg/g. However, those with eGFR 45-59 or 15-44 ml/min/1.73 m2 and UACR ≥30 mg/g had higher risk of the primary outcome (HR [95% CI], 1.97 [1.27, 3.04] and 3.32 [2.23, 4.93], respectively). The risk for all-cause death was higher for each category of abnormal eGFR and UACR, with the highest risk observed among those with eGFR 15-44 ml/min/1.73 m2 and UACR ≥30 mg/g (3.34 [2.05, 5.44]). Limitations: Individuals with diabetes and urine protein >1 g/day were excluded from SPRINT. Conclusion: Among older adults SPRINT participants, low eGFR without albuminuria was associated with higher mortality but not with increased risk of cardiovascular events. Additional studies are needed to evaluate an adapted CKD stage-based risk stratification for older adults.pdfengNational Kidney FoundationKidney MedicineKidney MedVol. 6 No. 7, (2024 )KDIGOCKDAlbuminuriaSPRINT trialCardiovascular eventsChronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trialinfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/articleArtículo científicohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_2df8fbb1Chronic Kidney Disease in the United States, 2023. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2023. Published June 26, 2023. Accessed September 8, 2023. https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.htmlKidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. 2012;2(4):64. http://www.kidney-international.orgDelanaye P, Jager KJ, Bökenkamp A, et al. CKD: A Call for an Age-Adapted Definition. JASN. 2019;30(10):1785-1805. doi:10.1681/ASN.2019030238Glassock RJ, Delanaye P, Rule AD. Should the definition of CKD be changed to include age-adapted GFR criteria? YES. Kidney Int. 2020;97(1):34-37. doi:10.1016/j.kint.2019.08.033Glassock R, Denic A, Rule AD. When kidneys get old: an essay on nephro-geriatrics. J Bras Nefrol. 2017;39(1):59-64. doi:10.5935/0101-2800.20170010Glassock RJ, Denic A, Rule AD. The conundrums of chronic kidney disease and aging. J Nephrol. 2017;30(4):477-483. doi:10.1007/s40620-016-0362-xZhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG. The aging kidney. Kidney Int. 2008;74(6):710-720. doi:10.1038/ki.2008.319O’Sullivan ED, Hughes J, Ferenbach DA. Renal Aging: Causes and Consequences. J Am Soc Nephrol. 2017;28(2):407-420. doi:10.1681/ASN.2015121308O’Hare AM, Rodriguez RA, Rule AD. Overdiagnosis of Chronic Kidney Disease in Older Adults-An Inconvenient Truth. JAMA Intern Med. 2021;181(10):1366-1368. doi:10.1001/jamainternmed.2021.4823Musso CG, Jauregui JR. How to differentiate renal senescence from chronic kidney disease in clinical practice. Postgrad Med. 2016;128(7):716-721. doi:10.1080/00325481.2016.1209963Liu P, Quinn RR, Lam NN, et al. Accounting for Age in the Definition of Chronic Kidney Disease. JAMA Intern Med. 2021;181(10):1359-1366. doi:10.1001/jamainternmed.2021.4813Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials. 2014;11(5):532-546. doi:10.1177/1740774514537404The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. doi:10.1056/NEJMoa1511939Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;Suppl 3:1-150.Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471-481. doi:10.7326/0003-4819-157- 7-201210020-00003Schaeffner ES, Ebert N, Kuhlmann MK, et al. Age and the Course of GFR in Persons Aged 70 and Above. Clin J Am Soc Nephrol. 2022;17(8):1119-1128. doi:10.2215/CJN.16631221Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421-426. doi:10.1001/jama.286.4.421Hillege HL, Fidler V, Diercks GFH, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777-1782. doi:10.1161/01.cir.0000031732.78052.81Gansevoort RT, Matsushita K, van der Velde M, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80(1):93-104. doi:10.1038/ki.2010.531Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514-525. doi:10.1016/S2213-8587(15)00040-6Astor BC, Matsushita K, Gansevoort RT, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79(12):1331-1340. doi:10.1038/ki.2010.550Minutolo R, Lapi F, Chiodini P, et al. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study. Clin J Am Soc Nephrol. 2014;9(9):1586-1593. doi:10.2215/CJN.10481013Malmgren L, McGuigan FE, Berglundh S, Westman K, Christensson A, Åkesson K. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women. Nephron. 2015;130(4):245-255. doi:10.1159/000435790Musso CG, Ricardo AC, Aroca-Martinez G. The fourth wave in chronic kidney disease (CKD) classification: taking into account the aging kidney. Int Urol Nephrol. Published online May 26, 2023. doi:10.1007/s11255-023-03642-wCampbell DJ, Coller JM, Gong FF, et al. Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function. BMC Nephrol. 2021;22(1):152. doi:10.1186/s12882-021-02324-yMusso CG, Macías-Núñez JF. Renal Aging and Chronic Kidney Disease in the Elderly: Which Are the Differences? In: Musso CG, Jauregui JR, Macías-Núñez JF, Covic A, eds. Clinical Nephrogeriatrics: An Evidence-Based Guide. Springer International Publishing; 2019:13-20. doi:10.1007/978-3-030-18711-8_2Eckardt KU, Delgado C, Heerspink HJL, et al. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023;104(5):888-903. doi:10.1016/j.kint.2023.05.013Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110(1): 32-35.ORIGINALPDF.pdfPDFapplication/pdf698057https://bonga.unisimon.edu.co/bitstreams/0388ba63-36b9-405d-a1d9-93d260f51bee/download48a246f79846a95d8f60fcf806c22e40MD54LICENSElicense.txtlicense.txttext/plain; charset=utf-8381https://bonga.unisimon.edu.co/bitstreams/f33eb076-e29f-47ee-804d-2097049e306b/download733bec43a0bf5ade4d97db708e29b185MD52TEXTPDF.txtPDF.txtExtracted texttext/plain34207https://bonga.unisimon.edu.co/bitstreams/cd5c7cea-649e-435f-9fb8-f88f24053e60/download9b3c7af02929f6088e10c3b7560c65abMD53PDF.pdf.txtPDF.pdf.txtExtracted texttext/plain37897https://bonga.unisimon.edu.co/bitstreams/3ea16ed0-5102-421d-8c28-3ec7a56abe7f/downloadc7d37bd0424432fd8e5fbf44655b4d2bMD56THUMBNAILPDF.jpgPDF.jpgGenerated Thumbnailimage/jpeg6666https://bonga.unisimon.edu.co/bitstreams/27841eda-32aa-40c5-8e82-27f134dae84b/downloade1ba666e4736da80554528192656cb79MD55PDF.pdf.jpgPDF.pdf.jpgGenerated Thumbnailimage/jpeg6666https://bonga.unisimon.edu.co/bitstreams/ab4c9192-00ef-45a8-91f4-787823468890/downloade1ba666e4736da80554528192656cb79MD5720.500.12442/14676oai:bonga.unisimon.edu.co:20.500.12442/146762024-08-14 21:52:31.218open.accesshttps://bonga.unisimon.edu.coRepositorio Digital Universidad Simón Bolívarrepositorio.digital@unisimon.edu.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 |